The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetes.

The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetes.

Item
http://www.wikidata.org/entity/Q46134952
Alogliptin benzoate for management of type 2 diabetesImproved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism.Protective Effects of Vildagliptin against Pioglitazone-Induced Bone Loss in Type 2 Diabetic Rats.Fixed-dose combination of alogliptin/pioglitazone improves glycemic control in Japanese patients with type 2 diabetes mellitus independent of body mass index.Alogliptin: a review of its use in patients with type 2 diabetes mellitus.DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.Pharmacokinetics and clinical evaluation of the alogliptin plus pioglitazone combination for type 2 diabetes.Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus.An update on the clinical pharmacology of the dipeptidyl peptidase 4 inhibitor alogliptin used for the treatment of type 2 diabetes mellitus.Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes.Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double-blind placebo-controlled Phase 3 study in mainland China, Taiwan, and Hong Kong.The dynamic plasticity of insulin production in β-cells.Ethnic Differences in Efficacy and Safety of Alogliptin: A Systematic Review and Meta-Analysis.Practical strategies for improving outcomes in T2DM: The potential role of pioglitazone and DPP4 inhibitors.Add on DPP-4 inhibitor alogliptin alone or in combination with pioglitazone improved β-cell function and insulin sensitivity in metformin treated PCOS.
P2860

The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetes.

Item
http://www.wikidata.org/entity/Q46134952
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
The effect of alogliptin and p ...... recent-onset type 2 diabetes.
@en
The effect of alogliptin and p ...... recent-onset type 2 diabetes.
@nl
type
label
The effect of alogliptin and p ...... recent-onset type 2 diabetes.
@en
The effect of alogliptin and p ...... recent-onset type 2 diabetes.
@nl
prefLabel
The effect of alogliptin and p ...... recent-onset type 2 diabetes.
@en
The effect of alogliptin and p ...... recent-onset type 2 diabetes.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
The effect of alogliptin and p ...... recent-onset type 2 diabetes.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921